Corona Day

Thursday 30 September

Corona Day Programme

Click here to download a pdf of the Corona Day programme.
You may also scroll through the programme online in the box below.



Since it was first identified in December 2019, the SARS-CoV-2 virus has caused over 2 billion cases of the disease, COVID-19, and over 4.5 million deaths.

What have we learned so far?

What questions remain unanswered?

Scientifically, the COVID-19 pandemic has been marked by tremendous global cooperation in terms of information sharing and research collaboration between institutions, and across borders. In addition, there have been unprecedented levels of cooperation between research institutions, health services, public health institutes, governments, and international organisations – and communities. Nearly 8 billion people are participating in what is essentially a global experiment.

ECTMIH 2021 has dedicated an entire Congress Day to address these questions and more.

Topics will include:
  • international collaboration to control the COVID-19 pandemic – successes and challenges
  • the virus and our immunity
  • vaccine development and scientific collaboration
  • vaccine manufacturing and global distribution
  • the corona pandemic - what can we learn for migration as a determinant of health?
  • COVID-19 care in LMIC and long-COVID
  • panel discussion on global perspectives - prevention and control strategies
  • how do epidemics end?
Here are some highlights:
  • Dr John-Arne Røttingen
  • Dr Ahmed E. Ogwell OUMA
  • Prof Marion Koopmans
  • Prof Rebecca Jane Cox Brokstad
  • Carlos G. das Neves
  • Prof Linga Wang
  • Dr Cesar Munoz-Fontela
  • ... and more
Panel members
  • Dr Octavio Ferraz
  • Mahlet Kifle Habtemariam
  • Dr Camila Gianella
  • Dr Kristine Onarheim
  • Prof Thorkild Tylleskär
  • Prof Carlos G. das Neves
  • Dr Stig Tollefsen, Dr Frederik Kristensen
  • Prof Esperanza Diaz
  • Prof Hans Kristian Flaatten
  • Prof Siri Gloppen
  • Prof Lise Rakner
  • ... and more
Meet some of the Corona Day speakers ...

Name: Dr. Ahmed Ogwell Ouma
Institution: Deputy Director at Africa Centres for Disease Control and Prevention (Africa CDC)
Speciality: expertise in how government policy can and should respond to neglected health challenges

Date: 30 Sept.
Time: 9:25-9:45

Title: Africa and the COVID-19 pandemic – successes and challenges
Link to talk (will appear after conference – access to participants only)

Short bio
Dr. Ahmed OGWELL OUMA is an accomplished international civil servant and an expert in global health for over 25 years. He has worked globally for public health and has overseen implementation of numerous health policies in countries in Africa. Learn more.

Twitter: @laktarr001


Name: Prof Linfa Wang
Institution: Duke-NUS Medical School, Singapore
Speciality: zoonotic diseases, bat immunology and pathogen discovery

Date: 30 Sept.
Time: 10:05-10:25

Title: The SARS-CoV-2 virus
Link to talk (will appear after conference – access to participants only)

Short bio
Wang played a leading role in identifying bats as the natural host of the Severe Acute Respiratory Syndrome (SARS) virus. His research then extended from bat-borne viruses to better understand virus-bat interaction and how bats co-exist with a large number of viruses without developing clinical diseases. His recent research contributions include developing antibody based serological tests to detect the SARS-CoV-2 virus, responsible for the COVID-19 outbreak, and the early and successful culture of the virus from an infected patents sample. Learn more.


Name: Dr Melanie Saville
Institution: Director of Vaccine Research & Development, Coalition for Epidemic Preparedness Innovation (CEPI)
Speciality: physician specialized in virology

Date: 30 Sept.
Time: 11:05-11:20

Title: Unprecedented investment and speed in the response to COVID-19 and moving towards a 100-day ambition
Link to talk (will appear after conference – access to participants only)

Short bio
Dr Saville leads a technical team who have oversight of the CEPI funded vaccines in development. She has contributed to the development and licensure of several vaccines for seasonal and pandemic influenza, paediatric combinations, Rabies, Japanese Encephalitis and Dengue vaccine in Europe, US and internationally. Learn more.


Name: Dr Cesar Munoz-Fontela
Institution: Bernhard Nocht Institute for Tropical Medicine, WHO task force
Speciality: immunologist, emerging Infections

Date: 30 Sept.
Time: 11:35-11:50

Title: Enabling science and collaboration in the pandemic
Link to talk (will appear after conference – access to participants only)

Short bio
Dr Cesar Munoz-Fontela is the Head of a Research Group at Bernhard Nocht Institute for Tropical Medicine working with how immune systems respond against infection with hemorrhagic fever viruses, in particular filoviruses such as Ebola and Marburg virus. He is also a consultant for the World Health Organization (WHO) Global Outbreak Alert and Response Network as well as a member of the WHO Ebola Science Committee.


Name: Dr Erica Charters
Institution: Faculty of History, University of Oxford
Speciality: history of war, disease, and bodies, particularly in the British and French empires, and How Epidemics End

Date: 30 Sept.
Time: 17:02-17:42

Title: How do epidemics end?
Link to talk (will appear after conference – access to participants only)

Short bio
Charters is interested in global approaches to history, both for research and teaching. Since disease was the biggest threat to manpower in the early modern world, she considers how disease environments – throughout the world – shaped military, commercial, and agricultural power, as well as how overseas experiences shaped European theories of medicine, biology, and race alongside political methodologies such as statistics and censuses. Learn more from her Oxford website, and from her blog.

Twitter: @EricaCharters